National Institutes of Health to Grant Exclusive Patent License for Cancer Diagnosis and Prognosis Methods

Summary

The National Institutes of Health is considering granting an exclusive patent license to BioncoDx, LLC for its cancer diagnosis and prognosis methods, as outlined in patent applications.